Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded ‘21st Century BA/BE’ project

Bart Hens, Patrick D Sinko, Nicholas Job, Meagan Dean, Jozef Al-Gousous, Niloufar Salehi, Robert M. Ziff, Yasuhiro Tsume, Marival Bermejo, Paulo Paixão, James G. Brasseur, Alex Yu, Arjang Talattof, Gail Benninghoff, Peter Langguth, Hans Lennernäs, William L. Hasler, Luca Marciani, Joseph Dickens, Kerby Shedden, Duxin Sun, Gregory E. Amidon, Gordon L. Amidon

Open source

DOI: 10.1016/j.ijpharm.2018.06.050
Published: 2018-09
Container: International Journal of Pharmaceutics
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2018.06.050,
  title = {Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded ‘21st Century BA/BE’ project},
  author = {Bart Hens and Patrick D Sinko and Nicholas Job and Meagan Dean and Jozef Al-Gousous and Niloufar Salehi and Robert M. Ziff and Yasuhiro Tsume and Marival Bermejo and Paulo Paixão and James G. Brasseur and Alex Yu and Arjang Talattof and Gail Benninghoff and Peter Langguth and Hans Lennernäs and William L. Hasler and Luca Marciani and Joseph Dickens and Kerby Shedden and Duxin Sun and Gregory E. Amidon and Gordon L. Amidon},
  year = {2018},
  journal = {International Journal of Pharmaceutics},
  doi = {10.1016/j.ijpharm.2018.06.050},
  url = {https://doi.org/10.1016/j.ijpharm.2018.06.050}
}

RIS

TY  - JOUR
TI  - Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded ‘21st Century BA/BE’ project
AU  - Bart Hens
AU  - Patrick D Sinko
AU  - Nicholas Job
AU  - Meagan Dean
AU  - Jozef Al-Gousous
AU  - Niloufar Salehi
AU  - Robert M. Ziff
AU  - Yasuhiro Tsume
AU  - Marival Bermejo
AU  - Paulo Paixão
AU  - James G. Brasseur
AU  - Alex Yu
AU  - Arjang Talattof
AU  - Gail Benninghoff
AU  - Peter Langguth
AU  - Hans Lennernäs
AU  - William L. Hasler
AU  - Luca Marciani
AU  - Joseph Dickens
AU  - Kerby Shedden
AU  - Duxin Sun
AU  - Gregory E. Amidon
AU  - Gordon L. Amidon
PY  - 2018
JO  - International Journal of Pharmaceutics
DO  - 10.1016/j.ijpharm.2018.06.050
UR  - https://doi.org/10.1016/j.ijpharm.2018.06.050
ER  -

APA

Hens, B., Sinko, P. D., Job, N., Dean, M., Al-Gousous, J., Salehi, N., Ziff, R. M., Tsume, Y., Bermejo, M., Paixão, P., Brasseur, J. G., Yu, A., Talattof, A., Benninghoff, G., Langguth, P., Lennernäs, H., Hasler, W. L., Marciani, L., Dickens, J., Shedden, K., Sun, D., Amidon, G. E., & Amidon, G. L. (2018). Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded ‘21st Century BA/BE’ project. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.06.050

Source records

crossref · retrieved 2026-09-26T01:31:37.131Z